comparemela.com

Latest Breaking News On - Endpoints news - Page 29 : comparemela.com

Five things for pharma marketers to know: Wednesday, April 12, 2023

Judge denies Elizabeth Holmes' request to stay out of prison while she appeals fraud conviction; The White House launches a $5 billion effort to develop next-generation COVID-19 vaccines.

White houseDistrict of columbiaUnited statesElizabeth holmeOperation warpEndpoints news

Five things for pharma marketers to know: Friday, April 7, 2023

Takeda to halt discovery and preclinical work in AAV gene therapy and rare hematology; Anti-vaccine activist Robert F. Kennedy Jr. files paperwork to run for president.

Mark roithmayrRonald lauderRobertf kennedy jrCenters for medicareAlzheimer drug discovery foundationMedicaid servicesAssociated pressEndpoints newsDrug discoveryMedicare advantage

Countries look to rewrite laws, other tactics to reduce drug shortages

Countries look to rewrite laws, other tactics to reduce drug shortages
umn.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from umn.edu Daily Mail and Mail on Sunday newspapers.

United statesTom bollykyTanya alcornUniversity of torontoEuropean union eu commissionBrookings institutionCouncil on foreign relationsTherapeutic goods administrationEuropean unionShoo leeEndpoints newsForeign relations

Five things for pharma marketers to know: Wednesday, April 5, 2023

Arbutus Biopharma sues Pfizer and BioNTech over COVID-19 vaccine patent infringement claims; Biogen appoints Adam Keeney as its head of corporate development.

New jerseyUnited statesAdam keeneyChris viehbacherArbutus biopharmaEndpoints news

Following clinical setbacks, NGM Bio lays off 33% of staffers as founder departs

Following clinical setbacks, NGM Bio lays off 33% of staffers as founder departs
endpts.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from endpts.com Daily Mail and Mail on Sunday newspapers.

Vir biotechnologyMarianne de backerEndpoints news

vimarsana © 2020. All Rights Reserved.